Racial/Ethnic Disparities in Access to Transportation Among Persons with Type 2 Diabetes Mellitus
Heather F McClintock1, Sarah E Edmonds2, Evangeline Wang3
1Department of Public Health, College of Health Sciences, Arcadia University, 450 S. Easton Rd, Glenside, PA, USA. devriesmcclintockh@arcadia.edu.
Journal of Racial and Ethnic Health Disparities
|January 13, 2025
Summary
Racial and ethnic disparities exist in reliable transportation access for individuals with type 2 diabetes mellitus (T2DM). Targeted initiatives are crucial to ensure equitable transportation solutions for this population.
Area of Science:
- Public Health
- Health Disparities
- Transportation Equity
Background:
- Lack of reliable transportation hinders access to healthcare and resources for individuals with type 2 diabetes mellitus (T2DM).
- Limited research has explored race/ethnicity-specific differences in transportation access among those with T2DM.
Purpose of the Study:
- To investigate whether access to reliable transportation for individuals with T2DM varies by race/ethnicity.
- To identify potential disparities in transportation access based on racial and ethnic groups.
Main Methods:
- Analysis of the 2022 Behavioral Risk Factor Surveillance System data for individuals with T2DM.
- Assessed reliable transportation access for medical appointments, work, and daily living within the past year.
- Employed weighted logistic regression to examine the association between race/ethnicity and transportation access, controlling for covariates.
Main Results:
- Black, American Indian/Alaskan Native (AI/AN), and multi-racial individuals with T2DM were significantly more likely to report lacking reliable transportation compared to White individuals.
- Factors associated with reduced likelihood of transportation issues included being female, older, married, higher income, employed, and having no mobility issues or depression.
- Self-rated health status from fair to very good was also linked to a lower likelihood of reporting transportation challenges.
Conclusions:
- Race/ethnicity is associated with disparities in reliable transportation access among individuals with T2DM.
- There is a critical need for initiatives to promote racially and ethnically equitable transportation access for people managing T2DM.
Related Concept Videos
Carbohydrate Metabolism
10.8K
Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
10.8K
Diabetes Mellitus: Overview and Type I Subtype
2.4K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.4K
Diabetes: Symptoms, Diagnosis, and Complications
500
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
500
Diabetes: Management and Pharmacotherapy
233
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
233
Pathophysiology of Diabetes
859
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
859
Glucose Transporters
22.4K
Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
22.4K


